IPF - Idiopathic Pulmonary Fibrosis

IPF - Idiopathic Pulmonary Fibrosis

Bibliographic Details
Format:	Article
Language:	English
Published:	European Respiratory Society 2019-06-01
Series:	Breathe
Online Access:	http://breathe.ersjournals.com/content/15/2/153.full

Similar Items

MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)
by: Gali Epstein Shochet, et al.
Published: (2021-01-01)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
by: Jaana Kaunisto, et al.
Published: (2019-07-01)

Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)
by: Ekaterina Krauss, et al.
Published: (2019-07-01)

Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study
by: Gabriela Leuschner, et al.
Published: (2020-11-01)

Idiopathic pulmonary fibrosis (IPF) in upper Egypt, a single center study
by: M. Alaa Rashad, et al.
Published: (2015-10-01)

Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
by: James Patrick Finnerty, et al.
Published: (2021-12-01)

Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
by: Ross Summer, et al.
Published: (2024-01-01)

A scoping review of the unmet needs of patients diagnosed with idiopathic pulmonary fibrosis (IPF)
by: Carita Bramhill, et al.
Published: (2024-01-01)

HSP90 Inhibition and Modulation of the Proteome: Therapeutical Implications for Idiopathic Pulmonary Fibrosis (IPF)
by: Ruben Manuel Luciano Colunga Biancatelli, et al.
Published: (2020-07-01)

Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)
by: Paola Confalonieri, et al.
Published: (2022-06-01)

Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism
by: Elisabetta Cocconcelli, et al.
Published: (2022-12-01)

Management and attitudes about IPF (Idiopathic Pulmonary Fibrosis) among physicians from Latin America
by: Iván Cherrez-Ojeda, et al.
Published: (2018-01-01)

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
by: Andreas Guenther, et al.
Published: (2018-07-01)

Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
by: Jamie L. Todd, et al.
Published: (2019-10-01)

Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials
by: Michael Kreuter, et al.
Published: (2019-04-01)

There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF)
by: Shabarinath Nambiar, et al.
Published: (2021-04-01)

The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—Approaching with Next-Generation Sequencing and Bioinformatics
by: Wei-An Chang, et al.
Published: (2020-11-01)

A high-throughput cell culture model of idiopathic pulmonary fibrosis (IPF) for gene therapy applications
by: Cerezuela, MP, et al.
Published: (2022)

Therapeutic potential of polyphenols against aging- induced idiopathic pulmonary fibrosis (IPF) via Bioinformatics analysis
by: Ankit Tripathi, et al.
Published: (2024-02-01)

Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)
by: Shaney L. Barratt, et al.
Published: (2018-01-01)

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
by: Michael Kreuter, et al.
Published: (2017-07-01)

Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry
by: Helen E. Jo, et al.
Published: (2018-01-01)

Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry
by: Jing Gao, et al.
Published: (2021-02-01)

South–West of England’s Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
by: Shaney L. Barratt, et al.
Published: (2018-12-01)

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry
by: Hiroshi Ishii, et al.
Published: (2023-11-01)

Sex Differences in the Incidence and Outcomes of Patients Hospitalized by Idiopathic Pulmonary Fibrosis (IPF) in Spain from 2016 to 2019
by: Belén López-Muñiz Ballesteros, et al.
Published: (2021-08-01)

Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
by: Kristina Krempaska, et al.
Published: (2020-01-01)

Evaluation of Regional Pulmonary Ventilation in Spontaneously Breathing Patients with Idiopathic Pulmonary Fibrosis (IPF) Employing Electrical Impedance Tomography (EIT): A Pilot Study from the European IPF Registry (eurIPFreg)
by: Ekaterina Krauss, et al.
Published: (2021-01-01)

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
by: Laurie Snyder, et al.
Published: (2019-05-01)

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
by: Jamie L. Todd, et al.
Published: (2020-03-01)

Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
by: Yangjin Jegal, et al.
Published: (2022-04-01)

Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
by: Davide Biondini, et al.
Published: (2021-04-01)

Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification
by: Monica Palermo, et al.
Published: (2021-01-01)

Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
by: Tejaswini Kulkarni, et al.
Published: (2024-03-01)

Myriad Functions of Stanniocalcin-1 (STC1) Cover Multiple Therapeutic Targets in the Complicated Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)
by: Shinya Ohkouchi, et al.
Published: (2015-01-01)

A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol
by: Caroline Wright, et al.
Published: (2019-10-01)

Ischemia-Modified Albumin (IMA) Is Associated with Poor Survival in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF): A Pilot Study
by: Angelo Zinellu, et al.
Published: (2024-02-01)

Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg)
by: Ekaterina Krauss, et al.
Published: (2020-11-01)

A Soft Voting Ensemble-Based Model for the Early Prediction of Idiopathic Pulmonary Fibrosis (IPF) Disease Severity in Lungs Disease Patients
by: Sikandar Ali, et al.
Published: (2021-10-01)

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
by: Michael Kreuter, et al.
Published: (2019-03-01)